Loading company…
ReCor Medical, Inc., based in Palo Alto, US, develops ultrasound renal denervation devices for treating hypertension.
Founded in 2009 and headquartered in Palo Alto, California, ReCor Medical develops medical devices for hypertension, chiefly the PARADISE Ultrasound Renal Denervation System, which targets reduced office systolic blood pressure in patients with treatment-resistant hypertension. CEO Andy Weiss leads the company. In July 2018 it raised USD 15.00 mn in a Series D round led by Otsuka Pharmaceutical Co., Ltd. to support the global commercialization of its PARADISE system.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in